Mustang Bio (MBIO) shares surged 340% after the company said Monday that updated data from its phase 1/2 clinical trial of MB-106 indicated a 90% overall response rate in Waldenstrom macroglobulinemia blood cancer patients previously treated with Bruton's tyrosine kinase inhibitors.
More than 800 million shares traded intraday versus a daily average of roughly 3.2 million.
Aaron's (AAN) said Monday it has agreed to be acquired by fintech firm IQVentures for $10.10 per share in cash for an enterprise value of approximately $504 million.
Shares rallied more than 32% as intraday trading volume advanced to more than 5.9 million from a daily average of roughly 233,000.
Autodesk (ADSK) shareholder Starboard Value said Monday that it plans to sue Autodesk and its board for allegedly failing to disclose material accounting and disclosure issues.
Starboard is seeking to leverage a now-completed internal investigation that resulted in no financial restatement as a pretext for re-opening the advance notice period, Autodesk said in a statement Monday.
Autodesk shares rose 7% as intraday trading volume climbed to more than 3.0 million versus the stock's daily average of about 1.9 million.
Price: 0.57, Change: +0.44, Percent Change: +340.00
Comments